Comments
Loading...

Sonnet BioTherapeutics Stock Price, Quotes and Forecasts

SONNNASDAQ
Logo brought to you by Benzinga Data
$1.50
-0.05-3.23%
Edge Rankings

Sonnet BioTherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SONN | Benzinga

Explore Sonnet BioTherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SONN.

Open-
Close-
Volume / Avg.4.00 / 1.03M
Day Range- - -
52 Wk Range1.38 - 18.72
Market Cap$4.60M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest-
Days to Cover1.54

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Dec 24
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open-
Close-
Volume / Avg.4.00 / 1.03M
Day Range- - -
52 Wk Range1.38 - 18.72
Market Cap$4.60M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest-
Days to Cover1.54
About Sonnet BioTherapeutics Holdings Inc
Sector
Health Care
Industry
Biotechnology

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SONN

FAQ

Q

How do I buy Sonnet BioTherapeutics (SONN) stock?

A

You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sonnet BioTherapeutics (SONN) competitors?

A

There are no as such competitors for Sonnet BioTherapeutics.

Q

What is the forecast, or price target, for Sonnet BioTherapeutics (SONN) stock?

A

Sonnet BioTherapeutics has a consensus price target of $10.18.

Q

What is the current price for Sonnet BioTherapeutics (SONN)?

A

The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $1.5 last updated February 28, 2025 at 4:56 PM EST.

Q

Does Sonnet BioTherapeutics (SONN) pay a dividend?

A

There are no upcoming dividends for Sonnet BioTherapeutics.

Q

When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?

A

Sonnet BioTherapeutics’s Q2 earnings are confirmed for Tuesday, May 13, 2025.

Q

Is Sonnet BioTherapeutics (SONN) going to split?

A

There is no upcoming split for Sonnet BioTherapeutics.

Q

What sector and industry does Sonnet BioTherapeutics (SONN) operate in?

A

Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.